CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell CarcinomaSumanta K. Pal(City of Hope), Samer A. Srour(The University of Texas MD Anderson Cancer Center)Cancer DiscoveryApril 4, 202410.1158/2159-8290.cd-24-0102Cited by 133SaveCiteExport RISWatch citationsRelated PapersNivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial|Nature Medicine|2022|453Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration‐resistant prostate cancer (CRPC)|Cancer|2017|88